🇺🇸 FDA
Patent

US 12201684

Compositions for stimulation of mammalian innate immune resistance to pathogens

granted A61KA61K2039/54A61K2039/55516

Quick answer

US patent 12201684 (Compositions for stimulation of mammalian innate immune resistance to pathogens) held by The Board of Regents of the University of Texas System expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/54, A61K2039/55516, A61K2039/55561, A61K31/7125